Enhancement of Stroke Rehabilitation With Levodopa
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 610 participants.
Also called NCT03735901
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 610 participants
- Registry
-
NCT03735901
-
- Other papers using this trial's data
- Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial
- The impact of levodopa on post-stroke depression: the ESTREL-depression-study
- Time course of motor recovery after stroke with and without levodopa: a post hoc 6-month longitudinal analysis of the ESTREL trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03735901. Randomized; quadruple masking; primary purpose treatment. Start 2019-06-14 (actual); primary completion 2024-08-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Enhancement of Stroke Rehabilitation With Levodopa
- Acronym
- ESTREL
- Condition
- Acute Stroke
- Condition
- Stroke Rehabilitation
- Intervention (Drug)
- IMP Levodopa 100mg/Carbidopa 25mg
- Intervention (Drug)
- Matching placebo
- Lead sponsor
- University Hospital, Basel, Switzerland
- Collaborator
- Swiss National Science Foundation
Record details
- Record id
cardio:ct-nct03735901- Content hash
5da35a4178a13fca07a523e51f1b4449cbaf71cbdda0bd8a8c1a1efc935ba8ea